Evidence map›Paper›PMID 33854118›Full record

ArticleScientific reports2021

Exploration of prognostic factors for critical COVID-19 patients using a nomogram model.

Juan Li, Lili Wang, Chun Liu, Zhengquan Wang, Yi Lin, Xiaoqi Dong, Rui Fan

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Treating asthma in the time of COVID.The Journal of allergy and clinical immunology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Juan Li *Nursing Department, Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang, China.
Lili Wang *Nursing Department, Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang, China.
Chun Liu *Division of Cardiothoracic and Vascular Surgery Department, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Zhengquan WangEmergency Medicine Department, Yuyao People's Hospital, Medical School of Ningbo University, Ningbo, Zhejiang, China.
Yi LinDepartment of Respiratory, The Affiliated Xiangshan Hospital of Wenzhou Medial University, Ningbo, Zhejiang, China.
Xiaoqi DongRespiration Department, Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang, China.
Rui FanMedical Quality Management Office, Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang, China. frnbdx@126.com.

Funding

The General Research Project of Zhejiang Provincial Department of Education Y202043652
6 · The paper itself

Abstract

The study aimed to explore the influencing factors on critical coronavirus disease 2019 (COVID-19) patients' prognosis and to construct a nomogram model to predict the mortality risk. We retrospectively analyzed the demographic data and corresponding laboratory biomarkers of 102 critical COVID-19 patients with a residence time ≥ 24 h and divided patients into survival and death groups according to their prognosis. Multiple logistic regression analysis was performed to assess risk factors for critical COVID-19 patients and a nomogram was constructed based on the screened risk factors. Logistic regression analysis showed that advanced age, high peripheral white blood cell count (WBC), low lymphocyte count (L), low platelet count (PLT), and high-sensitivity C-reactive protein (hs-CRP) were associated with critical COVID-19 patients mortality risk (p < 0.05) and these were integrated into the nomogram model. Nomogram analysis showed that the total factor score ranged from 179 to 270 while the corresponding mortality risk ranged from 0.05 to 0.95. Findings from this study suggest advanced age, high WBC, high hs-CRP, low L, and low PLT are risk factors for death in critical COVID-19 patients. The Nomogram model is helpful for timely intervention to reduce mortality in critical COVID-19 patients.

Indexed as

AgedAged, 80 and overAge FactorsBiomarkersComorbidityCOVID-19C-Reactive ProteinCritical IllnessFemaleHumansLogistic ModelsLymphocyte CountMaleMiddle AgedModels, TheoreticalNomogramsBiomarkersC-Reactive Protein

Identifiers

PMID33854118
PMCPMC8046984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.